Adjuvant intravesical mitoxantrone after transurethral resection of primary superficial transitional cell carcinoma of the bladder. A prospective randomised study
- 31 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (2) , 143-146
- https://doi.org/10.1016/0959-8049(94)00453-c
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase I-II evaluation of intravesical novantrone (mitoxantrone) in superficial bladder cancerAnti-Cancer Drugs, 1991
- Intravesikale Langzeitchemoprophylaxe mit Mitomycin C beim oberflächlichen Harnblasenkarzinom - Rezidivverhalten und Progression nach 3 JahrenAktuelle Urologie, 1988
- Natural History and Treatment of Low and High Risk Superficial Bladder TumorsJournal of Urology, 1988
- Urothelial Histopathology Surrounding Bladder CarcinomasEuropean Urology, 1987
- Long-Term Mitomycin C Instillation After Transurethral Resection of Superficial Bladder Carcinoma: Influence on Recurrence, Progression and SurvivalJournal of Urology, 1984
- Does Intravesical Chemotherapy Prevent Invasive Bladder Cancer?Journal of Urology, 1984
- Long-term Fate of 90 Patients with Superficial Bladder Cancer Randomly Assigned to Receive or not to Receive ThiotepaJournal of Urology, 1983
- Benign Papilloma or Papillary Carcinoma of the Bladder?Journal of Urology, 1973
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958